INTRODUCTION
Vitamin A (VA) and its metabolite retinoic acid (RA) play critical roles in gut immunity. VA supplementation significantly reduces the mortality of undernourished infants, largely by reducing the severity of infectious diarrhea. 1 VA or RA deficiency is also induced by fat malabsorption resulting from disorders, such as pancreatic insufficiency, cholestatic liver diseases, cystic fibrosis, sprue, or inflammatory bowel diseases, or from defective VA metabolism as observed in alcoholism. [2] [3] [4] Dendritic cells (DCs) in gut-related lymphoid organs express the key RA-generating enzyme retinal dehydrogenase 2 (RALDH2; aldehyde dehydrogenase 1A2, ALDH1A2) and thus can produce RA from retinol, the basic form of VA. 5, 6 
RALDH2
þ DCs express CD103, and these cells also exist in the lamina propria of the small intestine. [7] [8] [9] RA imprints guthoming specificity on naive T and B cells upon activation. 5, 10 Thus, VA deficiency causes the depletion or reduction of T cells and immunoglobulin A (IgA)-producing B cells from the small intestinal lamina propria. RA also regulates the functional differentiation of T cells. It suppresses T helper type 1 (Th1) differentiation both directly and indirectly, and reciprocally enhances Th2 differentiation under certain conditions. 11 Accordingly, VA deficiency reduces antibody responses to T cell-dependent antigens and T cell-independent type 2 antigens but not T cell-independent type 1 antigens such as lipopolysaccharide. 12, 13 RA also enhances the transforming growth factor-b (TGF-b)-dependent generation of forkhead box P3 (Foxp3) þ inducible regulatory T cells, but suppresses Th17 generation. 7, 8, 14 The RA-dependent generation of guttropic Foxp3 þ inducible regulatory T cells appears to be important for oral tolerance. [15] [16] [17] However, the generation of Th1 and Th17 cells also appears to require RA. 18, 19 Furthermore, in conjunction with IL-15, RA acts as an adjuvant to promote Th1-dependent inflammation. 20 VA or RA deficiency also affects the nature of DCs, especially mesenteric lymph node (MLN)-DCs. RALDH2 expression is nearly absent in MLN-DCs of VA( À ) mice. 6, 9, 21 The langerin þ CD8a À CD11b low/ þ CD103 þ DC population increases in MLNs. 22 Here we unexpectedly found that MLN-DCs of unprimed VA( À ) mice induced the differentiation of naive CD4
þ T cells to a distinct subset of inflammatory Th2 cells that particularly produced high levels of interleukin-13 (IL-13) and tumor necrosis factor-a (TNF-a) as well as Th17 cells. IL-6-and OX40 ligand (OX40L)-mediated signals appeared to be required for the optimal induction of these IL-13-producing inflammatory Th2 cells, whereas TGF-b suppressed the induction. Th17 cytokines contribute to inflammatory and autoimmune diseases, 23 whereas IL-13 plays critical roles in inflammatory and allergic diseases including asthma, [24] [25] [26] [27] ulcerative colitis, 28, 29 and atopic dermatitis. 30 IL-13 is also a major stimulator of tissue remodeling and fibrosis in various tissues, including the liver, lungs, and skin. 25 Thus, we speculated that MLN-DCs of VA( À ) mice (VA( À )MLN-DCs) may participate in the induction of oral antigen-specific inflammatory or allergic responses in an IL-13-dependent manner. Indeed, VA( À ) mice that received repeated oral antigen administration exhibited IL-13-dependent strong IgG1 responses and subsequent IgE responses upon antigen challenge with an adjuvant. We suggest that RA plays a critical role in the inhibition of inflammatory or allergic responses to oral antigens partly by preventing MLN-DCs from inducing IL-13-producing inflammatory Th2 cells.
RESULTS

MLN-DCs of VA( À ) mice efficiently induce IL-13-producing inflammatory Th2 cells and Th17 cells
We first evaluated the ability of DCs obtained from various lymphoid organs of VA( À ) and VA( þ ) mice to induce functional naive CD4 þ T-cell differentiation. VA( À )MLNDCs induced T cells to express markedly higher levels of E-and P-selectin ligands, Ccr2, Ccr4, Ccr5, and Ccr6, but lower levels of Ccr9 compared with VA( þ )MLN-DCs (Figure 1a-c) . The proteins encoded by these genes are involved in T-cell homing to inflammatory sites or the skin. 31 Indeed, T cells activated with VA( À )MLN-DCs preferentially migrated into inflamed skin (Figure 1d ). In the presence of TGF-b, VA( þ )MLN-DCs induced the expression of Foxp3 and CD103 on T cells, whereas VA( À )MLN-DCs induced the weak expression of these molecules ( Figure 1e) . VA deficiency had a much lesser impact on the ability of DCs from other lymphoid organs to induce T cells to express these molecules, except for splenic (SPL)-DCs, and induce Ccr4 expression (Figure 1a,b) .
T cells induced by VA( À )MLN-DCs produced higher levels of IL-4, IL-9, IL-13, IL-17A, IL-21, and TNF-a upon activation than those induced by VA( þ )MLN-DCs (Figure 2a) . In particular, IL-13 and TNF-a levels were strikingly higher. Most of the IL-13-producing T cells expressed TNF-a but not interferon-g (IFN-g) or IL-17A (Figure 2b ), suggesting that these T cells were inflammatory Th2 cells. However, they produced low levels of IL-5 unlike previously described inflammatory Th2 cells (Figure 2a) . 32 Thus, these IL-13-producing T cells appear to be a distinct subset of inflammatory Th2 cells. On the other hand, T cells induced by DCs from Peyer's patches (PPs) of VA( À ) or VA( þ ) mice produced low levels of cytokines except for IFN-g (Figure 2a ). T cells induced by DCs from the skin-draining peripheral lymph nodes (PLNs) of VA( À ) mice produced significantly higher levels of IL-17A, IL-21, and TNF-a, and lower levels of IFN-g, IL-4, and IL-10 than those induced by VA( þ )PLN-DCs. T cells induced by VA( À )SPL-DCs produced higher levels of IFN-g and IL-10 than those induced by VA( þ )SPL-DCs, but their production levels of other cytokines were low. These results suggest that VA deficiency facilitates PLN-DCs to induce Th17 cells, but most strikingly affects the nature of MLN-DCs and causes them to induce IL-13-producing inflammatory Th2 and Th17 cells that express homing receptors for inflammatory sites or the skin.
VA deficiency enhances inflammatory signatures in conventional DCs (cDCs) of MLNs VA( À )MLN-DCs expressed higher levels of Il6, Il12b (encodes IL-12p40), and Tnfsf4 (encodes OX40L), but lower levels of Il10, Tgfb1, and Mmp9 (encoding matrix metallopeptidase 9 that activates TGF-b) compared with VA( þ )MLN-DCs (Figure 3a) . Thus, VA( À )MLN-DCs may have a predominant inflammatory nature. B220 À cDCs from VA( À )MLNs expressed higher levels of CD40, CD86, and major histocompatibility complex class II, but lower levels of CD103 than those from VA( þ )MLNs (Figure 3b ). On the other hand, VA deficiency did not significantly affect the surface marker expression on PP-cDCs or B220 þ plasmacytoid DCs (pDCs) of MLNs (Supplementary Figure S1 online). In PP-pDCs, however, VA deficiency increased the proportion of CCR9 Figure S1b) , the phenotype of which resembled that of tolerogenic CCR9 þ pDCs. 33 The VA status did not significantly affect surface marker expression on SPL-DCs and PLN-DCs (data not shown). These results collectively suggest that VA deficiency increases the proportion of inflammatory mature or activated cells in the MLN-cDC population.
The CD8a
À CD11b þ CD103 À cDC subset of MLNs in VA( À ) mice instructs naive CD4 þ T cells to differentiate into IL-13-producing inflammatory Th2 cells in an IL-6-dependent manner To identify the DC subset responsible for IL-13-producing inflammatory Th2 induction, we fractionated VA( À )MLNDCs (Figure 3c ). VA deficiency most strikingly affected surface marker expression in the CD8a
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MucosalImmunology | VOLUME 7 NUMBER 4 | JULY 2014 subset ( Figure 3d ). The R2 subset expressed Il6, Il12b, and Tnfsf4, but only low levels of Il12a (encodes IL-12p35) and Il23a (encodes IL-23p19) ( Figure 3e ). VA deficiency especially enhanced the expression of Il6, Il12b, and Tnfsf4. IL-13-producing cells were induced most strongly by R2, moderately by the CD8a À CD11b þ CD103 þ cDC (R3) subset, and weakly by the other cDC subsets (Figure 4a) . However, IL-17A-producing cells were induced most strongly by R3 and slightly less strongly by R2. Both R2 and R3 induced TNF-a-producing cells. IFN-g-producing cells were most efficiently induced by the CD8a þ CD11b À cDC (R1) subset and less efficiently by R2 (Figure 4a ). T cells stimulated with R2 or R3 expressed Ccr2, Ccr4, Ccr5, and Ccr6 (Supplementary Figure S2a) and high levels of E-and P-selectin ligands (Supplementary Figure S2b) . The results suggest that R2 and R3 most efficiently induce IL-13-producing inflammatory Th2 and Th17, respectively, and that these T cells are tropic to the skin or inflammatory sites.
We then analyzed the mechanism of IL-13-producing inflammatory Th2 induction by R2. An IL-6-neutralizing antibody inhibited the induction of IL-13-, IL-17A-, or TNF-aproducing T cells (Figure 4b) . Neutralizing antibodies against IL-12p40 and IL-23p19 suppressed the induction of IL-13-producing cells but not of IL-17A-producing cells. The results suggest that IL-6 and monomeric IL-12p40 or its homodimer IL-12p80 participate in IL-13-producing inflammatory Th2 induction and that IL-6 but not IL-12p40 is required for Th17 induction. The balance between the IL-13-producing inflammatory Th2 and Th17 subsets in T cells stimulated with VA( À )MLN-cDCs slightly varied according to the experiments. OX40L expression on DCs is known to contribute to the induction of inflammatory Th2 cells. 32 An OX40L-blocking antibody partly inhibited the ability of R2 to induce IL-13-producing T cells, but enhanced its ability to induce IL-17A-producing T cells (Figure 4b) . These results suggest that IL-6 is essential for the induction of both IL-13-producing inflammatory Th2 and Th17 cells, and that OX40L-mediated signals affect the IL-13-producing inflammatory Th2/Th17 balance. À CD11c þ cDCs into two major CD8a þ (R1) and CD8a À subsets. CD8a À cDCs were further subdivided into CD11b inducing T cells that produced high levels of IL-13, IL-17A, TNF-a, or IFN-g ( Figure 5a ). However, the RAR antagonists LE135 or LE540 enhanced the ability of MLN-DCs of normal mice to induce IL-13-, IL-17A-, or TNF-a-producing T cells (Figure 5b ). In the presence of LE135 or LE540, the CD8a À CD11b þ CD103 À (R2) MLN-cDC subset of normal mice induced T cells that produced high levels of IL-13, IL-17A, and TNF-a ( Figure 5c ). IL-17A-producing T cells were also induced by the CD8a
subsets. R1 induced IFN-g-producing T cells in the presence of LE135. Importantly, each cDC subset was differentially affected by RAR antagonists with regard to the induction of cytokine-producing T cells. The LE540-dependent normal R2-mediated induction of IL-13-, IL-17A-, and TNF-a-producing T-cell subsets was abrogated by a neutralizing antibody against IL-6 and partly abrogated by an antibody against IL-12p40 ( Figure 5d) . A blocking antibody against OX40L partly inhibited the induction of IL-13-and TNF-a-producing T cells but not of IL-17A-producing T cells. À / À mice were stimulated with ovalbumin (OVA) peptide and MLN-DC subsets (R1, CD8a 
þ cDCs) of normal mice in the presence or absence of LE135 or LE540, and were restimulated with immobilized mAbs to CD3 and CD28. Cytokine concentrations in the supernatants were assessed by ELISA. *Po0.05; **Po0.01; ***Po0.001 vs. absence of LE135 and LE540. (d) CD4
þ T cells were stimulated with OVA peptide, LE540, and the CD8a À CD11b þ CD103 À (R2) subset of MLN-cDCs from normal mice in the presence of anti-OX40L, anti-IL-6, anti-IL-12p40, or isotype control mAbs, and were restimulated with immobilized mAbs to CD3 and CD28. Cytokine concentrations in the supernatants were assessed by ELISA. Results are shown as the percentage of the control culture with the isotype control mAb. *Po0.05; **Po0.01; ***Po0.001; NS, not significant vs. control mAb. Data are presented as mean þ s.d. of quadruplicate samples. Representative results from three independent experiments are shown.
These results suggest that in normal mice, MLN-DCs possess the latent ability to induce IL-13-producing inflammatory Th2 and Th17 cell differentiation, and that RA prevents the differentiation of these T cells by modulating the nature of MLN-cDCs, especially R2 and R3.
IL-6 instructs naive T cells to differentiate into IL-13-producing inflammatory Th2 cells
We examined whether IL-6 and other molecules could directly induce IL-13-producing inflammatory Th2 differentiation. In a DC-free culture system, naive CD4 þ T cells that were Figure S3) . A plate-bound agonistic anti-OX40 antibody failed to affect T-cell cytokine production. However, the anti-OX40 antibody facilitated normal MLN-DCs to induce T cells that produced high levels of IL-4, IL-5, IL-13, and TNF-a (Figure 6c) . IL-12p80 moderately Figure 6 Interleukin-6 (IL-6) instructs naive T cells to differentiate into IL-13-producing inflammatory T helper type 2 (Th2) cells. CD4 þ T cells from BALB/c mice were stimulated with immobilized monoclonal antibodies (mAbs) to CD3 and CD28 in the presence or absence of (a) IL-6, IL-12p70, IL-12p80 (10 ng ml ), soluble anti-OX40, or Rat IgG1 isotype control mAbs (10 mg ml À 1 ), and were restimulated with immobilized mAbs to CD3 and CD28. Cytokine concentrations in the supernatants were assessed ELISA. Data are presented as mean þ s.d. of triplicate samples. *Po0.05; **Po0.01; ***Po0.001. Similar results were obtained from three independent experiments.
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MucosalImmunology | VOLUME 7 NUMBER 4 | JULY 2014 facilitated MLN-DCs to induce Th2 cells. However, the addition of IL-6 rather suppressed the induction of IL-13-producing T cells, and enhanced the induction of IL-17A-producing T cells. TGF-b from MLN-DCs may contribute to this result. These findings collectively suggest that IL-6-dependent signals are essential for the specific induction of IL-13-producing inflammatory Th2 and that TGF-b can regulate IL-13-producing inflammatory Th2 induction. On the other hand, OX40-mediated signals and IL-12p80 likely contribute to skew T cells toward general inflammatory Th2 or Th2-related cell subsets, including IL-13-producing inflammatory Th2.
Proximal colon epithelial cells in VA-deficient mice produce TNF-a that can instruct DCs to express OX40L VA deficiency also affects the nature of intestinal epithelial cells, and can direct them to produce inflammatory cytokines that induce OX40L expression in DCs. 32, 34, 35 Indeed, VA deficiency markedly enhanced TNF-a expression in proximal colon epithelial cells (Figure 7a,b) . As lymph from the proximal colon drains into the MLNs, TNF-a production may affect the nature of MLN-DCs. TNF-a induced the expression of OX40L, CD40, and CD86 in murine fms-related tyrosine kinase 3 ligand (Flt3L)-generated bone marrow (BM)-DCs and the production of low levels of IL-6, and RA partly suppressed this induction except for CD40 and IL-6 (Figure 7c,d ). TNF-a-treated BMDCs instructed T cells to produce extremely high levels of IL-4, IL-5, and IL-13 in an OX40L-dependent manner (Figure 7e and f). RA partly suppressed this production. Thus, in VA( À ) mice, TNF-a may enhance the ability of MLN-DCs to induce general inflammatory Th2 cells. Accordingly, injections of anti-TNF-a antibody into VA( À ) mice for 2 weeks tended to downregulate this ability (data not shown). These results suggest that VA or RA can also regulate the nature of MLN-DCs by suppressing both TNF-a production in the proximal colon and TNF-a signaling in MLN-DCs.
IL-33-expressing cells and thymic stromal lymphopoietinexpressing cells were detected in the MLNs, PPs, small intestine, and proximal colon of unprimed VA( À ) mice as frequently as that in VA( þ ) mice. However, VA deficiency increased the number of IL-33-expressing epidermal cells in the ear (data not shown). IL-33, but not thymic stromal lymphopoietin, induced the CD86, IL-6, and low levels of OX40L and CD40 expression in BM-DCs, and RA partly suppressed this induction (Supplementary Figure S4 and data not shown).
VA deficiency increases the risk of strong immune responses to oral antigens As MLN-DCs can present oral antigens, we re-examined whether VA deficiency affected oral tolerance, using a classical system of tolerance induction. Mice received repeated intragastric administration of ovalbumin (OVA), followed by challenges of OVA with an adjuvant. In VA( þ ) mice, regardless of the route of challenge, repeated OVA administration significantly reduced the OVA-induced proliferation of draining MLN or PLN cells in vitro compared with saline administration (Figure 8a-c) . In VA( À ) mice, however, repeated OVA administration did not significantly reduce cell proliferation (Figure 8a-c) , except for PLN-cell proliferation when assessed 1 week after the subcutaneous challenge (Figure 8c, left) . The latter result agreed with a previous observation under similar conditions. 22 However, PLN cells obtained from OVA-fed VA( À ) mice 2 weeks after the subcutaneous challenge proliferated equally to those obtained from saline-fed control mice (Figure 8c, right) as reported previously. 17 Unexpectedly, however, MLN cells obtained from OVA-fed VA( À ) mice 1 week after intraperitoneal (i.p.) challenge exhibited higher proliferation levels than those from saline-fed control mice (Figure 8a) . After repeated OVA feeding, CD4 þ T cells from the MLNs and SPLs of VA( À ) mice, but not VA( þ ) mice, produced significant levels of IL-13 and IL-17A upon antigenic stimulation (Figure 8d) , indicating that antigen feeding can induce antigen-specific IL-13-producing T cells and IL-17A-producing T cells in VA( À ) mice.
Repeated oral antigen administration primes strong antibody responses
In VA( þ ) mice, OVA feeding suppressed the serum and fecal antibody responses after two i.p. challenges as expected (Figure 9a,b) . However, OVA-fed VA( À ) mice exhibited aberrantly high serum levels of anti-OVA IgG1 and IgG2a responses (Figure 9a) . The total IgG1 and IgG2a concentrations in the sera of these mice reached 6-10 mg ml À 1 and 2.0-2.2 mg ml À 1 , respectively. The anti-OVA IgA levels in the sera of these mice were also significantly higher than those in OVA-fed VA( þ ) or saline-fed VA( À ) mice. Furthermore, significant anti-OVA IgE responses were induced in OVA-fed VA( À ) mice. In these mice, a single intradermal OVA injection elicited ear swelling that peaked at B6 h after the OVA challenge (Figure 9c,d) , suggesting that IgE-mediated and mast cell-dependent immediate-type allergic inflammation was induced. Two i.p. challenges, however, spontaneously induced deaths in some VA( À ) mice. Elevated antibody responses in the OVA-fed VA( À ) mice were already observed after the first i.p. challenge (Supplementary Figure S5) . These results suggest that repeated oral antigen administration strongly primes VA( À ) mice for antigen-specific antibody responses, especially IgG1 responses, and eventual IgE responses that cause allergic skin inflammation. In saline-fed control mice, however, VA deficiency suppressed the OVAspecific serum antibody and fecal IgA antibody responses, as expected (Figure 9a,b) . Fecal anti-OVA IgG1 antibodies were detected in OVA-fed VA( À ) mice (Figure 9b) , suggesting that the intestinal mucosal barrier functions were reduced in VA( À ) mice after repeated antigen administration. IL-13 is essential for anti-OVA IgG1, IgA, and IgE antibody responses in OVA-pre-fed VA( À ) mice IL-13 and IL-21 promote IgG1 antibody production, whereas IL-17A and IL-21 promote IgG2a antibody production. 36, 37 Thus, IL-13-producing inflammatory Th2 or Th17 cells may contribute to oral antigen-specific IgG1 and IgG2a antibody responses. To examine the role of IL-13 in antibody responses, sera were obtained from Il13 À / À VA( À ) mice after repeated is essential for the disruption of oral tolerance in T cells of VA( À ) mice.
DISCUSSION
VA deficiency affects the nature of MLN-DCs even in unprimed mice. In particular, the CD8a À CD11b þ CD103 À cDC (R2) subset of VA( À )MLN-DCs exhibited the ability to instruct naive CD4 þ T cells to differentiate into IL-13-producing inflammatory Th2 cells in an IL-6-dependent manner. IL-6 alone efficiently induced IL-13-producing inflammatory Th2 cells from naive CD4 þ T cells upon activation with antibodies to CD3 and CD28, indicating that IL-6-mediated signaling is essential and sufficient for IL-13-producing inflammatory Th2 induction in the absence of DCs. TGF-b1 downregulated IL-13-producing inflammatory Th2 induction, and reciprocally upregulated Th17 induction, suggesting that TGF-b levels in the microenvironment regulate the IL-13-producing inflammatory Th2/Th17 balance.
OX40/OX40L-mediated signaling also appeared to participate in IL-13-producing inflammatory Th2 induction by enhancing the generation of general inflammatory Th2 cells and suppressing that of Th17 cells. VA( À )MLN-DCs expressed much higher levels of Tnfsf4 than VA( þ )MLNDCs. However, among VA( À )MLN-DCs, the R3 subset expressed higher levels of Tnfsf4 than R2, despite the fact that R2 induced IL-13-producing inflammatory Th2 more efficiently than R3. An agonistic anti-OX40 antibody affected IL-13-producing inflammatory Th2/Th17 balance in the presence of MLN-DCs, suggesting that T cell/DC interactions mediated by other molecules could also be involved. In VA( À ) mice, TNF-a produced by epithelial cells in the proximal colon may flow into the draining MLNs and partly contribute to the induction of inflammatory Th2 cells by enhancing OX40L expression in MLN-DCs, although further analysis is necessary. IL-12p40 also appeared to participate in the R2-mediated generation of IL-13-producing inflammatory Th2 but not Th17 cells. The homodimer IL-12p80 inhibits IL-12-mediated responses and contributes to Th2-type allergic diarrhea. 38 Accordingly, IL-12p80 moderately enhanced Th2 induction. Th1-derived IFN-g is known to suppress both Th2 and Th17 differentiation. 39 Interestingly, CD103 þ MLN-DCs of VA( À ) mice produce IFN-g upon stimulation.
40 IFN-g may contribute to the difference in the nature of R2 and R3. The nature of R3 may also be influenced by CD103 þ langerin þ immunosuppressive DCs, which are found in VA( À )MLNs.
22 R2-and R3-stimulated T cells produced low levels of IL-4, but these levels may still influence general Th2 skewing.
IL-13-producing inflammatory Th2 and Th17 may also influence each other. IL-13 attenuates Th17 cytokine production. 41 However, IL-17A enhances downstream IL-13 signals. 42 IL-13 appeared to be essential for the aberrant proliferation of T cells from VA( À ) mice. The underlying mechanism remains to be clarified, but IL-13-producing inflammatory Th2 may have been the major influence on proliferating T cells in the MLN culture or could have induced IL-13-producing inflammatory Th2 proliferation in an autocrine manner. The complex interplay of cytokines is likely to influence IL-13-producing inflammatory Th2 induction. IL-13-producing inflammatory Th2 cells induced by VA( À ) MLN-DCs expressed homing receptors for inflammatory sites or the skin. Indeed, these cells could migrate into inflamed skin. In VA( À ) animals, the administration of food and bacterial antigens to the skin could thus pose a risk of IL-13-producing inflammatory Th2-dependent inflammation. IL-13-producing inflammatory Th2 cells that are primed in the MLNs could induce antigen-specific inflammatory responses in any tissues , b) OVA-or saline-fed VA( þ ) and VA( À ) mice (n ¼ 5 mice/group) were immunized intraperitoneally (i.p.) with 0.1 mg of OVA in alum 7 and 21 days after the last feeding. (a) The serum samples and (b) the fecal extracts were prepared 7 days after the last immunization, and were assessed by enzyme-linked immunosorbent assay (ELISA) for OVA-specific antibodies (n ¼ 5 VA( þ ) and n ¼ 3 VA( À ) mice/group, two out of five OVA-fed or saline-fed VA( À ) mice were dead after the second immunization). The antibody levels were defined by comparing with standard serum and expressed in arbitrary units (AU). Data are presented as mean þ s.e.m. for each group. *Po0.05; **Po0.01; ***Po0.001; NS, not significant. with innate inflammation and blood-borne antigens that could be increased with repeated oral antigen administration or an infectious gut insult under VA( À ) conditions. 43 Reductions in endogenous RA or VA concentrations have been observed in atopic dermatitis and other inflammatory diseases. 44, 45 Inflammatory Th2 cells often participate in these diseases. On the other hand, VA or RA treatment ameliorates various inflammatory diseases. 46 IL-13 is known to play central roles in asthma. [24] [25] [26] [27] As CCR4 contributes to T-cell lung imprinting, 47 IL-13-producing inflammatory Th2 cells may also be able to contribute to the antigen-specific asthmatic reaction. However, VA deficiency reduced disease severity in a mouse model of asthma induced by i.p. injections of OVA and alum, followed by exposures to aerosolized OVA. 48 In the absence of OVA feeding, we also observed lower antibody responses in VA( À ) mice compared with VA( þ ) mice. Antigen prefeeding appears to be critical in inducing unusually high antibody responses in VA( À ) mice. Nonetheless, relatively low dietary VA intake is known to be associated with asthma. 49 Strong IgG1 responses and IgE responses were induced against OVA, a T cell-dependent antigen, in VA( À ) mice. The IgE levels were sufficient to induce immediate-type allergic responses in the skin. However, previous reports suggested that VA deficiency reduces antibody responses to T cell-dependent antigens and T cell-independent-type 2 antigens. 12, 13 On the other hand, VA deficiency in rats enhanced bacterial translocation into the MLNs and the serum levels of IgG, IgM, and IgE antibodies against bacterial antigens including the T cell-independent antigen lipopolysaccharide. 13 Similarly, in unprimed mice, VA deficiency induced the elevation of serum IgG2a and IgG2b levels but not of IgG1, IgG3, or IgA levels. 10, 40 Commensal bacterial antigens such as lipopolysaccharide may contribute to this elevation. The strong IgG1 responses and IgE responses to OVA in the OVA-fed VA( À ) mice likely involve OVA-specific IL-13-producing inflammatory Th2 cells induced by VA( À )MLN-DCs. OVA feeding alone induced OVA-specific IL-13-producing CD4 þ T cells in the MLNs of VA( À ) mice. T cell-independent antigens derived from commensal bacteria may facilitate T-cell priming and the induction of antibody responses. Furthermore, additional adjuvant-induced signals may be necessary to trigger or enhance antibody responses. Foxp3 þ CD103 þ T cells are present even in mice with low VA levels. 50 Accordingly, VA( À )PP-DCs induced Foxp3
þ PP-pDCs in VA( À ) mice may be tolerogenic, as their phenotype resembled 
, and Il13 À / À VA( À ) mice (n ¼ 4-7 mice/group) were immunized intragastrically with 10 mg of OVA plus cholera toxin 7, 14, and 21 days after the last feeding. The serum samples were prepared 7 days after the last immunization assessed by enzyme-linked immunosorbent assay for OVA-specific antibodies. The antibody levels were defined by comparing with standard serum and expressed in arbitrary units (AU). Data are presented as mean þ s.e.m. for each group. ***Po0.001. Representative results from three independent experiments are shown. IgG1, immunoglobulin G1. (b) OVA-or saline-fed Il13 À / À VA( þ ) and Il13
À / À VA( À ) mice were immunized intragastrically with 10 mg of OVA plus cholera toxin 7 days after the last feeding. OVA-specific proliferation of draining mesenteric lymph node (MLN) cells was assessed 7 days after immunization. Data are presented as mean þ s.e.m., 4 mice/group. *Po0.05; ***Po0.001.
that of tolerogenic CCR9 þ pDCs. 33 Nonetheless, in VA( À ) mice, oral antigen-specific inflammatory effector T cells including IL-13-producing inflammatory Th2 and Th17 appear to overcome the effect of regulatory T cells.
RA is required for immature DCs to express RALDH2. 6, 21, 51 Bile retinoids contribute to the induction of RALDH2 expression in lamina propria-DCs and MLN-DCs. 9 Therefore, liver dysfunction may affect RALDH2 expression in gut CD103
þ DCs by reducing the production of bile retinoids and other components necessary for the intestinal absorption of lipids including RA precursors. Accordingly, young children with severe liver dysfunction have a high prevalence of food allergies, with specific IgE responses. 52 The presence of RARa appears to be critical for CD4 þ T-cell activation and differentiation. 18, 53 In VA( À ) mice, weak RARa signaling induced by residual levels of retinol or other molecules may be necessary for inducing inflammatory arms of immunity. Indeed, the retinol levels in our VA( À ) mouse sera were o1/10 of the control but not completely absent. Therefore, the present results suggest that VA insufficiency in the gut increases the risk of IL-13-dependent inflammatory or allergic diseases by inducing oral antigen-specific IL-13-producing inflammatory Th2 cells as well as the risk of Th17-dependent diseases by changing the nature of MLN-DCs.
METHODS
Mice. BALB/c, C57BL/6, and DO11.10/Rag2
À / À mice were obtained from CLEA Japan (Tokyo, Japan) and Taconic (Hudson, NY), respectively. BALB/c Il13 À / À mice were generated by backcrossing B6x129 Il13 À / À mice (kindly provided by Dr Andrew McKenzie, MRC Laboratory of Molecular Biology, Cambridge, UK).
36 VA( À ) and VA( þ ) mice were generated as previously described. 6 All mice were maintained in specific pathogen-free conditions in the animal facility of Tokushima Bunri University (Kagawa, Japan). All animal experiments were performed according to protocols approved by the Animal Care and Use Committee of Tokushima Bunri University.
Cell preparation. DCs were isolated by MACS (Miltenyi Biotec, Bergisch Gladbach, Germany) as previously described. 6 Sorting of DC subsets was performed on a FACSAria (BD, Franklin Lakes, NJ) after staining with fluorochrome-conjugated monoclonal antibodies (mAbs) against CD11c, B220, CD8a, CD11b, and CD103 (Supplementary Table S1 online). Naive CD4 þ CD62L high T cells were obtained from lymph nodes and SPLs of DO11.10/Rag2 À / À mice by negative selection using EasySep Mouse CD4 þ T Cell Enrichment Kits (Stemcell Technologies, Vancouver, BC, Canada). In some experiments, naive CD4 þ CD62L high CD44 À T cells were obtained from SPLs of BALB/c or C57BL/6 mice by negative selection using EasySep Mouse CD4 þ T Cell Enrichment Kits supplemented with biotinylated anti-CD44 mAb (IM7; BioLegend, San Diego, CA) and subsequently by positive selection with CD62L Microbeads (Miltenyi Biotec). To isolate proximal colon epithelial cells, the proximal colon was incubated with Hanks' balanced salt solution containing 1 mM dithiothreitol as previously described. 6 BMDCs were generated by culturing BM cells for 7 days in the presence of 20% culture supernatant of a mouse Flt3L-transfected CHO cell line, and then stimulated with 50 ng ml À 1 TNF-a (Peprotech, Rocky Hill, NJ) or 100 ng ml À 1 IL-33 (BioLegend) in the presence or absence of 10 nM all-trans-RA for 48 h. 54 Naive CD4 þ T cells (1 Â 10 5 ) from BALB/c or C57BL/6 mice were cultured for 3 days in the plates coated with anti-CD3 mAb (3 mg ml À 1 ) and anti-CD28 mAb (3 mg ml À 1 ) with or without anti-OX40 or Rat IgG1 isotype control (10 mg ml À 1 ). The culture was diluted with twice its volume of fresh medium, transferred into new wells, and cultured for 3 days. Cytokines were added at the start of each culture. For the experiment in Figure 6b , TGF-b1 (R&D Systems) was used after reconstituting in 4 mM hydrochloric acid containing 1 mg ml
bovine serum according to the manufacturer's protocol. To assess T-cell cytokine production, the cells (1 Â 10 5 ) were resuspended and cultured for 3 days in the plates coated with anti-CD3 mAb (3 mg ml À 1 ) and anti-CD28 mAb (3 mg ml À 1 ). Cytokine levels in the culture supernatants were analyzed by enzyme-linked immunosorbent assay (ELISA). Table S1 ) in the presence of anti-CD16/CD32 mAb (2.4G2; BD). Staining of E-and P-selectin ligands was performed as previously described. 6 Intracellular staining of Foxp3 was performed using mouse/rat Foxp3 staining sets (eBioscience). For intracellular cytokine staining, CD4 þ T cells obtained from cultures were restimulated with immobilized anti-CD3 mAb (10 mg ml À 1 ) and soluble anti-CD28 mAb (5 mg ml À 1 ) in the presence of monensin (2 mM) for 6 h. The cells were fixed and permeabilized with Fixation/ Permeabilization Buffers (eBioscience), and intracellular cytokine staining was performed according to the manufacturer's protocol. Analysis was performed on a FACSCalibur (BD) or FACSAria with CellQuest Pro software (BD).
Real-time PCR. Total RNA was isolated from cells using RNeasy Kit (Qiagen, Hilden, Germany), and complementary DNA was generated using QuantiTect Reverse Transcription Kit (Qiagen). Complementary DNA was used as a template for real-time PCR in triplicates with Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and gene-specific primers (Supplementary Table S2 ). PCR analyses were performed on a 7500 RealTime PCR system (Applied Biosystems). The expression of each gene was normalized with Rplp0, and relative expression was quantified with the 2 À DCt value multiplied by 1,000.
Homing assay. CD4 þ DO11.10/Rag2 À / À T cells activated with VA( þ )MLN-DCs or VA( À )MLN-DCs were differentially labeled with 5-chloromethylfluorescein diacetate and SNARF s -1 carboxylic acid acetate succinimidyl ester (Life Technologies, Carlsbad, CA) as previously described. 55 An aliquot (2-3 Â 10 7 ) of the cells was injected intravenously into each BALB/c mouse with preexisting cutaneous inflammation in both ears induced by a standard delayed hypersensitivity protocol as previously described 31 with modification. In brief, shaved abdomens of the mice were painted with 50 ml 0.5% 2,4-dinitro-1-fluorobenzene (Nacalai tesque, Kyoto, Japan) in acetone/ olive oil (4:1) on day 0. On day 5, mice were challenged with 20 ml 0.3% 2,4-dinitro-1-fluorobenzene on both ears, and used on the next day as recipients for competitive homing experiments. Recipients were killed 16 h after the adoptive transfer, and the transferred cells were recovered from MLNs and both ears after digestion with collagenase type VIII (Sigma-Aldrich). To assess the migration efficiency of the transferred cells, the ratios of SNARF-1 þ cells/CMFDA þ cells in recipient tissues were analyzed by flow cytometry.
Immunohistochemical analysis. MLNs, tissue blocks of the small intestine with PP, proximal colon, and ear from VA( þ ) and VA( À ) mice were immersion-fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2). The fixed tissues were immersed in 20% sucrose in 0.1 M phosphate buffer overnight for cryoprotection, embedded in O.C.T. compound (Sakura Finetek Japan, Tokyo, Japan), and then frozen on dry ice. Frozen sections (8 mm thick) of these tissues were cut out and thaw-mounted onto silane-coated glass slides. These sections were blocked with 5% normal donkey serum (Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. The sections were incubated with rabbit anti-TNF-a (Abcam, Cambridge, MA) at 4 1C for at least 48 h followed by the incubation with Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch) for 1 h at room temperature. TO-PRO-3 (Molecular Probes, Eugene, OR) was used for nuclear staining. Immunostained sections were coverslipped with glycerol and observed using a confocal laser scanning microscopy (FV-1000; Olympus, Tokyo, Japan).
Induction of oral tolerance and immunization. Mice were fed 10 mg of OVA (grade V; Sigma-Aldrich) or saline alone by gavage 5 times every other day (on days 0, 2, 4, 6, and 8). The mice were immunized with 0.1 mg of OVA in adjuvant (2 mg of Imject Alum (Thermo Fisher Scientific, Waltham, MA) for i.p., or complete Freund's adjuvant (Sigma-Aldrich) for subcutaneous administration) 7 days after the last feeding (day 15). In some experiments, the mice were immunized intragastrically with 10 mg of OVA and 10 mg of cholera toxin (List Biological Laboratories, Campbell, CA). OVA-specific proliferation of draining lymph node cells was assessed 7 or 14 days after immunization (day 22 or 29). To assess antibody responses, OVA-or salinefed mice were immunized i.p. with 0.1 mg of OVA in alum 7 and 21 days after the last feeding (on days 15 and 29), whereas the other mice were immunized intragastrically with 10 mg of OVA plus cholera toxin 7, 14, and 21 days after the last feeding (on days 15, 22, and 29). The serum and the rectal feces of each mouse were collected 7 days after the last immunization (day 36). Feces were adjusted to a 100 mg ml À 1 concentration in phosphate-buffered saline containing protease inhibitors (Complete, Mini; Roche Applied Science, Indianapolis, IN) and 0.1% sodium azide. The feces were homogenized, incubated for 1 h on ice, and centrifuged for 15 min at 20,000 g to remove solid material. To assess CD4 þ T-cell cytokine production, MLNs and SPLs were obtained from the OVA-or saline-fed mice without subsequent immunization 24 h after the last feeding. CD4 þ cells were isolated by positive selection with CD4 Microbeads (Miltenyi Biotec). Aliquots (4 Â 10 5 ) were cultured with irradiated SPL cells (1 Â 10 6 ) and OVA (1 mg ml À 1 ) for 3 days. Cytokine levels in the culture supernatants were analyzed by ELISA.
Antigen-induced ear swelling assay. VA( þ ) and VA( À ) mice fed OVA 5 times were immunized with two i.p. injections of OVA/alum as described above. At 7 days after the last immunization, the left ears of mice were intradermally administered with 10 mg of OVA in 10 ml of phosphate-buffered saline, and their right ears were administered an equal amount of phosphate-buffered saline by using a microsyringe (1701LT; Hamilton, Reno, NV). Ear thickness was measured with a dial thickness gage (No. 7331; Mitsutoyo, Kanagawa, Japan). ELISA. Cytokine levels in the culture supernatants were analyzed with ELISA kits for IFN-g, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, TNF-a (BD), IL-9, IL-17A, IL-23p19 (BioLegend), IL-13, and IL-21 (R&D Systems). To detect OVA-specific antibodies, plates were coated with 20 mg ml À 1 OVA in 0.05 M carbonate-bicarbonate buffer (pH 9.6), and blocked with 5% normal goat serum (Sigma-Aldrich) in Tris-buffered saline. Serially diluted serum samples or fecal extracts and standard serum (pooled hyperimmune sera collected after i.p. immunization with 0.1 mg of OVA in alum 3 times at 2-week intervals) were added and incubated for 2 h. After washing, horseradish peroxidase-conjugated goat anti-mouse IgG1, IgG2a, or IgA (Bethyl Laboratories, Montgomery, TX) were added and incubated for 1 h. To detect anti-OVA IgE, biotinylated anti-mouse IgE (BioLegend) was added for 1 h, followed by addition of horseradish peroxidaseconjugated avidin (BioLegend). The reactions were developed with 3,3',5,5'-tetramethylbenzidine substrate (Sigma-Aldrich) and stopped with 1 M H 2 SO 4 . The absorbance at 450 nm was measured using a microplate reader (Bio-Rad Laboratories, Hercules, CA). OVA-specific antibody levels were defined by comparing with standard serum and expressed in arbitrary units (AU). Total antibodies were analyzed with ELISA kits for mouse IgG1, IgG2a, IgA (Bethyl Laboratories), and IgE (BioLegend).
Statistical analysis. Statistical comparisons were carried out using the one-way analysis of variance with Tukey-Kramer multiple comparisons test and the two-tailed unpaired Student's t-test. Values o0.05 were considered statistically significant.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
